Feline Fibrosarcoma

Overview

A malignant tumor arising from fibrous connective tissue, one of the more commonly diagnosed soft tissue sarcomas in cats — notable for a genuine tendency toward local invasion into surrounding tissue, similar in this respect to injection-site sarcoma (covered in its own entry, and indeed fibrosarcoma is the specific tumor type most commonly identified in that context), though fibrosarcoma can also occur at locations unrelated to any prior injection.

Symptoms

• Firm, growing mass under the skin (moderate, common)
• Mass feeling fixed to underlying tissue (advanced) (moderate, uncommon)

Causes

The specific underlying cause isn't well established for fibrosarcomas occurring independently of the injection-site context; when occurring at a prior injection site, the same chronic inflammation-related mechanism discussed in the Injection-Site Sarcoma entry is believed relevant. A malignant tumor of connective tissue, fibrosarcoma in cats is notably associated with injection sites in some cases (see Feline Injection-Site Sarcoma specifically), though it also occurs independent of any injection history — these tumors tend to be locally invasive, meaning they extend into surrounding tissue with root-like projections that make complete surgical removal more challenging than the visible tumor size alone might suggest.

Risk Factors

A history of injection at the affected site (for injection-associated cases, see that condition's own entry for the specific '3-2-1 rule' guidance); no other strongly established specific risk factor for fibrosarcomas occurring independently of this context.

Transmission

Not applicable — not an infectious or contagious condition.

Incubation Period

Not applicable.

Disease Stages & Progression

Tends to be locally invasive, growing into and involving surrounding tissue, similar to the pattern discussed for injection-site sarcoma specifically; can occur at various body locations depending on whether it's related to a prior injection or arising independently.

Early Warning Signs

A firm, growing mass under the skin, which may or may not correspond to a prior injection site.

Advanced Symptoms

A larger, more locally invasive mass, potentially affecting underlying structures depending on its specific location and extent.

Diagnostic Methods

Biopsy of the mass provides definitive diagnosis, confirming fibrosarcoma and distinguishing it from other possible tumor types or benign masses.

Veterinary Examination Process

Careful assessment of the mass's size, firmness, and mobility (whether it moves freely or feels fixed to underlying tissue, which can suggest more significant local invasion).

Recommended Lab Tests

Pre-treatment bloodwork; biopsy is the key diagnostic test.

Diagnostic Imaging

CT or MRI imaging assesses the tumor's local extent, valuable for surgical planning given this tumor type's tendency for local invasion; chest X-rays check for the less common but possible spread to the lungs.

Blood Test Indicators

Not specific to this condition; pre-treatment bloodwork assesses overall health.

Biopsy / Histopathology

Essential for diagnosis, confirming fibrosarcoma specifically and providing information relevant to prognosis and treatment planning.

Differential Diagnoses

Injection-site sarcoma specifically (when location correlates with prior injection), other soft tissue sarcoma types, and benign masses — biopsy is essential to distinguish these.

Home Monitoring Guidance

Not a substitute for veterinary evaluation of any growing mass — this needs prompt biopsy and treatment planning rather than continued home observation.

Veterinary Treatment Options

Aggressive, wide surgical excision — similar in principle to the approach discussed for injection-site sarcoma given fibrosarcoma's shared tendency for local invasion — is the cornerstone of treatment; radiation therapy is often recommended alongside surgery, particularly when complete surgical margins aren't achieved, to address any remaining microscopic tumor extension. Wide surgical excision, removing a substantial margin of apparently normal tissue around the visible tumor specifically to catch these microscopic extensions, is the standard approach; radiation therapy is often recommended following surgery given how commonly these tumors extend beyond what appeared to be complete surgical margins.

Surgery Requirements

Aggressive, wide surgical excision is the standard approach, reflecting this tumor type's genuine tendency for local tissue invasion.

Recovery Timeline

Recovery from the necessarily extensive surgery is typically several weeks; radiation therapy, where pursued, adds its own treatment course.

Possible Complications

Local recurrence is a genuine, well-recognized risk given this tumor type's locally invasive nature, similar to the concern discussed for injection-site sarcoma; less commonly, spread to the lungs.

Long-Term Management

Regular follow-up monitoring for local recurrence is important given the meaningful risk even after aggressive initial treatment.

Prevention

For injection-associated cases, the same preventive principles discussed in the Injection-Site Sarcoma entry apply (injection site selection, avoiding unnecessary repeated vaccination); no established prevention for fibrosarcomas arising independently of this context.

Vaccination Availability

Not applicable to this condition itself.

Prognosis

Guarded to fair, reflecting this tumor type's tendency for local recurrence; outcomes are generally better with early detection and sufficiently wide initial surgical excision, similar to the considerations discussed for injection-site sarcoma.

References

Veterinary Cancer Society; American College of Veterinary Surgeons (ACVS).

Medications Used

• Chemotherapy, in select cases depending on staging and behavior
• Pain management

Estimated Treatment Cost by Country

Frequently Asked Questions